Prelude Therapeutics to Participate in the Chardan Healthcare Conference
Prelude Therapeutics will participate in the Chardan Healthcare Conference in New York City on October 20, 2026. Chief Scientific Officer Peggy Scherle and CFO Bryant Lim will join a 2:00 p.m. ET fireside chat, with a live webcast and 90-day archive on the company website.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.